Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399

Watchlist Manager
Jiangsu Bioperfectus Technologies Co Ltd Logo
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Watchlist
Price: 64.61 CNY -1.51% Market Closed
Market Cap: 5.4B CNY

Net Margin
Jiangsu Bioperfectus Technologies Co Ltd

-7.7%
Current
-14%
Average
1.9%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-7.7%
=
Net Income
-26m
/
Revenue
339m

Net Margin Across Competitors

No Stocks Found

Jiangsu Bioperfectus Technologies Co Ltd
Glance View

Market Cap
5.4B CNY
Industry
Health Care

Jiangsu Bioperfectus Technologies Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents and supporting testing instruments. The company is headquartered in Taizhou, Jiangsu and currently employs 765 full-time employees. The company went IPO on 2019-12-05. The firm's products mainly include in vitro diagnostic reagents, supporting testing instruments and in vitro testing services. Its products are mainly used in the fields of infectious disease prevention and control, clinical testing, large-scale population screening, as well as prenatal and postnatal care management. The firm mainly conducts its businesses in domestic and overseas markets.

Jiangsu Bioperfectus Technologies Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-7.7%
=
Net Income
-26m
/
Revenue
339m
What is the Net Margin of Jiangsu Bioperfectus Technologies Co Ltd?

Based on Jiangsu Bioperfectus Technologies Co Ltd's most recent financial statements, the company has Net Margin of -7.7%.

Back to Top